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Objective. This study estimated the excess clinical, humanistic, and economic burden associated with depression among working-
age adults with Rheumatoid Arthritis (RA). Methods. A retrospective cross-sectional study was conducted among working-age
(18 to 64 years) RA patients with depression (𝑁 = 647) and without depression (𝑁 = 2,015) using data from the nationally
representative Medical Expenditure Panel Survey for the years 2009, 2011, 2013, and 2015. Results. Overall, 25.8% had depression.
In adjusted analyses, adults with RA and depression compared to those without depression were significantly more likely to have
pain interference with normal work (severe pain: AOR = 2.22; 95% CI = 1.55, 3.18), functional limitations (AOR = 2.17; 95% CI
= 1.61, 2.94), and lower mental health HRQoL scores. Adults with RA and depression had significantly higher annual healthcare
expenditures ($14,752 versus 10,541, 𝑝 < .001) and out-of-pocket spending burden. Adults with RA and depression were more
likely to be unemployed and among employed adults, those with depression had a significantly higher number of missed work days
annually and higher lost annual wages due to missed work days. Conclusions. This study highlights the importance of effectively
managing depression in routine clinical practice of RA patients to reduce pain and functional limitations, improve quality of life,
and lower direct and indirect healthcare costs.
1. Introduction
Rheumatoid Arthritis (RA) is one of the most debilitating
chronic conditions, with the onset often occurring during the
prime working years of lives, between the ages of 20 and 40
years [1]. Individuals with RA experience substantial pain and
RA causes permanent work disability in more than one-third
of affected patients within 10 years of onset [2]. Such pain
and disabilities associatedwith RAmay contribute to a higher
prevalence of depression in individuals with RA compared
to healthy controls [3]. An expert review of depression in
arthritis reported that the prevalence of depression in adults
with RA can be as high as 66.2% [4]. A systematic review and
meta-analysis of 72 studies estimated the prevalence rate to
be 16.8% [5].
The disease burden of depression in RA can be substantial
because depression can worsen survival [6] and increase
morbidity in terms of disability, health-related quality of life
(HRQoL), RA disease activity [7], and pain [8]. Depression in
RA can also increase healthcare resource utilization [9, 10],
which can lead to high health care expenditures for both
insurance payers, patients and families. As depression in
RA can aggravate disability, an individual may also suffer
economic losses due to work inability or even experience
economic losses due to missed work days. Although not
specific to RA, one study estimated that 6.9 million working-
age adults reported arthritis-attributable work limitation [11].
One can speculate that depression can worsen the work
limitation because the presence of depression along with any
chronic physical condition more than doubles the likelihood
of work absenteeism as compared to the presence of any
chronic physical condition without depression [12].
However, to date, no published study in the US has done
a comprehensive analysis of the humanistic and economic
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Figure 1: Flow diagram of study sample.
burden associated with depression among RA patients, par-
ticularly among working-age adults. In fact, a recent review
highlighted the significant knowledge gap in estimating
the disease burden of depression in adults with arthritis
[4]. Although there has been a handful of studies on the
association between depression and HRQoL among adults
with RA, most of these studies have been conducted outside
the US [13, 14] or only amongwomen in a specific setting [15].
One US study used a cross-sectional design and examined
the relationship between depression and disability, HRQoL
in the US with data from the 2011 Behavioral Risk Factor
Surveillance System [16]. However, this study included all
forms of arthritis and did not focus on RA. Again, only one
study using 2006 commercial claims data in the US found
that RA patients with depression had a significantly higher
adjusted annual healthcare costs as compared to RA patients
without depression ($12,225 versus $11,404) [9]. However,
this study was based on commercially insured RA patients
and may not be representative of the US national popula-
tion. Furthermore, this commercial insurance data did not
include certain patient characteristics which are important
confounders of healthcare costs such as race, education, and
income level.
Therefore, the objective of this study is to examine the
incremental burden of depression on the clinical, humanistic,
and economic outcomes among working-age adults with RA.
2. Methods
2.1. Study Design. A retrospective cross-sectional study
design with data from a nationally representative sample of
working-age adults (18–64 years) was used.
2.2. Data Source. We used data from the Medical Expen-
diture Panel Survey (MEPS), an annual household survey
of the noninstitutionalized civilian population in the US.
Information on demographic characteristics, medical condi-
tions, health status, utilization of health care services, charges
and payments, access to care, health insurance coverage,
income, education, employment, andmissed workdays of the
participants in the survey were extracted from the household
component of MEPS. We pooled four years of data (2009,
2011, 2013, and 2015) to have sufficient sample size and used
data from alternate years to avoid including two observations
per individual. Furthermore, a question related to the type
of arthritis was available in these years. MEPS recommends
pooling of data to increase sample size and it is a common
practice in published literature with MEPS data [17].
2.3. Study Sample. The study sample (𝑁 = 2,662) consisted
of working-age (18–64 years) who were diagnosed with RA
and who were alive during the study period (2009, 2011, 2013,
and 2015) (Figure 1). RA was identified from the priority
condition enumeration section. In this section, respondents
were queried whether an individual in the household has
ever been told by a doctor or another health professional
that she/he had arthritis and type of arthritis (RA versus
osteoarthritis). We also identified RA from medical condi-
tion file with the clinical classification code (202). Medical
conditions were reported by the respondents if they sought
treatment for the condition, or if the condition resulted in
disability, or if the condition was bothersome. The responses
were recorded as texts, and these texts were translated into
International Classification of Diseases, 9th Edition, Clinical
Modification (ICD-9-CM) codes by professional coders. In
addition, MEPS data provides clinical classification codes,
which are aggregated ICD-9-CM codes into clinically mean-
ingful categories that group similar conditions (Agency for
Healthcare Research and Quality).
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2.4. Conceptual Framework. The conceptual framework for
this study was adapted from the Andersen’s Expanded Behav-
ioral Model which posits that health services utilization and
outcomes of an individual are a function of predisposing
factors (e.g., age, sex, and race), enabling factors (e.g.,
marital status, education and poverty status), need factors
(e.g., chronic conditions, health status), and personal health
practices (e.g., physical activity, obesity, and smoking) [18].
2.5. Measures
2.5.1. Clinical Outcomes
Pain Interference with Normal Activities. Based on a self-
administered single-item question, pain interference with
normal activities during the past four weeks among the
household respondents was measured. The answers were
recorded on a 5-point Likert scale during the past 4 weeks. In
MEPS, painwas reported on a 5-point scale: (1) not at all, (2) a
little bit, (3) moderately, (4) quite a bit, and (5) extremely. For
purposes of this study we group pain categories as follows:
(1) not at all/little bit; (2) moderate; (3) severe (quite a
bit/extremely). Self-reported pain fromMEPS has been used
in published literature to estimate the cost of pain [19]. There
were 42 individuals (5.9%) in the depression group and 140
individuals (6.6%) in the no depression group with missing
data on pain inference variable. These individuals were not
included in the analysis.
Any Functional Limitations. This variable summarizes
whether an individual had any limitations in instrumental
activities of daily living (IADL) (e.g., shopping, cooking,
using phone, paying bills, taking medications, driving, doing
laundry, or going shopping), activities of daily living (ADL)
(e.g., bathing, dressing, grooming, mouthcare, toileting,
and eating), functional limitations (walking, climbing stairs,
grasping objects, reaching overhead, lifting, bending or
stooping, or standing for long periods of time), or activity
limitations (work, housework, or school).
2.5.2. Humanistic Outcome: Health-Related Quality of Life.
HRQoL was measured by the generic Short-Form-12 Version
2 (SF12-V2) summary scores. The SF12-V2 is a generic mul-
tipurpose survey with 12 questions, which encompass eight
domains (role physical, role emotional, physical function,
social function, mental health, vitality, pain, and general
health). These questions are designed to provide summary
measures of overall HRQoL of an individual. The Men-
tal Component Summary (MCS) score was derived from
the responses to the items in the domains: vitality, social
functioning, role emotional (limitations in work and daily
activities because of emotional problems), andmental health.
The Physical Component Summary (PCS) score was derived
from the responses to the items in the domains: physical
functioning, role physical, bodily pain, and general health.
Both MCS and PCS scores ranged from 0 to 100, with higher
scores representing better self-reported health and better
HRQoL related to mental or physical health [20].
2.5.3. Economic Outcomes: Direct Healthcare Expenditures
Total Healthcare Expenditures. In the MEPS, expenditures
are defined as the sum of direct payments for care provided
during the year. The direct payments include twelve sources
of payment categories such as out-of-pocket by patient or
families, Medicare, Medicaid, Private Insurance, Veteran
Administration, worker’s compensation, and others. Total
annual per person healthcare expenditures were calculated
as the sum of inpatient, outpatient, emergency, dental, home
health, vision, prescription drugs, and othermedical supplies.
All expenditures were inflation adjusted to 2015 US dollars
(USD) using consumer price index for medical services from
the bureau of medical services.
Total Out-of-Pocket Spending Burden by Patients and Fami-
lies. We also estimated the total out-of-pocket spending on
healthcare by the respondent and/or family. These included
annual deductibles, copayment, and coinsurance for services
and payment for services that were not covered by health
insurance. We calculated out-of-pocket spending burden
as the ratio of out-of-pocket healthcare expenditures to
personal income [21], which varied from zero to 100. Based
on published literature, we defined spending 10% or more
of personal income on health care as high out-of-pocket
spending burden [22].
2.5.4. Economic Outcomes: Indirect Healthcare Burden
Unemployment (i.e., Labor Market Outcome). In the MEPS,
employment section covers questions about each person’s
employment or self-employment status. Based on these ques-
tions, we classified individuals who were currently unem-
ployed.
Missed work daysweremeasured whether individuals lost
a half-day or more from work because of illness, injury, or
mental or emotional problems during the year and howmany
workdays were lost. This was calculated only for employed
adults.
Lost wages for each individual were calculated by multi-
plying missed work days with an average daily wage of each
individual. All wages were adjusted to 2015 general consumer
inflation rates derived from the bureau of labor statistics.
Key Explanatory Variable
Depression (Yes/No). Depression was identified based on
the clinical classification code “657,” which included both
depressive disorders and bipolar disorders.
Other Explanatory Variables. Predisposing characteristics
were sex (male, female), race/ethnicity (Whites, African-
American, and other racial minorities), and age in years
(18–39, 40–49, and 50–64). Enabling factors comprised mar-
ital status (married, widow, separated/divorced, and never
married), family poverty status (not poor, poor), health
insurance status (public, private), and usual source of care
(yes, no). Need factors included having a chronic condition
other than RA from a list of eight conditions (asthma,
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cancer, chronic obstructive pulmonary disease, diabetes,
heart disease, hypertension, stroke, and thyroid), anxiety,
perceived physical health status (excellent/very good, good,
and fair/poor), and perceived mental health status (excel-
lent/very good, good and fair/poor). Personal health practice
factors included obesity (obese and not obese), smoking
status (current smoker, others, and missing), and exercise
(“yes” and “no” exercise).
2.6. Statistical Analyses. A variety of statistical analyses were
used based on themeasurement of the outcome variables.The
unadjusted relationships between the presence of depression
and categorical variables and outcomes (pain interference
with activities, employment, and OOP burden) were assessed
with chi-square tests. Unadjusted differences in continuous
outcomes (PCS, MCS, all-cause healthcare expenditures, and
out-of-pocket spending by the patients and their families)
by depression were tested with 𝑡-tests. Multinomial logistic
regression was used to analyze the association between
depression and pain-related interference with normal work
after adjusting for the predisposing, enabling, need, and
external environment characteristics. Logistic regression was
used to analyze the association between depression and
binary categorical variables (e.g., any limitations, unemploy-
ment, and out-of-pocket spending burden) after adjusting
for covariates. Adjusted models for continuous outcomes
(expenditures, out-of-pocket expenditures, and lost wages)
consisted of Generalized Linear Models (GLM). GLM is
flexible and can handle categorical outcomes, continuous
outcomes, and count-data with the appropriate distribution
family and a link function. For count-data (e.g., the number
of missed work days) we used negative binomial regression.
Counterfactual Prediction Technique (Recycled Prediction).
Weused counterfactual recycled prediction, an approach that
is gaining attention [23, 24] to estimate excess total healthcare
expenditures, prescription expenditures, missed work days,
and lost wages attributable to depression among working-age
adults with Rheumatoid Arthritis. The recycled prediction
technique is a preferred approach because it adjusts for
differences in characteristics between the depression and
no depression group by creating counterfactual scenarios.
In all recycled prediction models, confidence intervals were
obtained using 2000 bootstrap replications using the per-
centile method. To account for the complex design of MEPS,
we conducted all analyses using the survey procedures in
Statistical Analysis Software (SAS) version 9.3, Cary, NC,
USA, and the survey design features with STATA 14. As
we pooled four years, to get annualized weighted num-
bers, we divided the weights by four, recommended by the
MEPS investigators [25] and used in the published literature
[26].
3. Results
3.1. Description of the Study Sample. Majority of the study
sample was female (64%) and white (63%), aged between 50
and 64 years (61%), and hadmultimorbidity (72%). Only 26%
of individuals who perceived themselves having excellent
or very good physical health and 44.8% reported having
excellent or very good mental health (see Table 1).
Overall, 25.8% of adults with RA reported depression
(Table 2). We observed significant differences in the rate of
depression by predisposing, enabling, need factors, and per-
sonal health practices except for age, education, and region.
For example, female adults with RA reported a significantly
higher rate of depression than theirmale counterparts (29.6%
versus 19.1%).The higher rate of depressionwas also observed
among individuals with multimorbidity (29.1% versus 17.4%).
A higher percentage of those who perceived themselves to
be poor/fair physical health reported depression compared to
those in excellent or very good health (38.0% versus 12.4%).
3.2. Clinical Outcomes
3.2.1. Pain Interference with Normal Activities. A higher
percentage of adults with RA and depression reported severe
pain interfering with work or other normal activities com-
pared to those with RA and no depression (54.8% versus
30.8%) (Table 3). After adjusting for predisposing, enabling,
need, personal health practices, and external environment
factors, and adults with depression were 2.2 times as likely to
report severe pain interference with normal work activities
than those without depression (AOR = 2.22; 95% CI = 1.55,
3.18) (Table 3).
3.2.2. Any Functional Limitations. A significantly higher
percentage of adults with RA and depression reported any
functional limitations compared to those with RA and no
depression (79% versus 51.1%) (Table 3). After adjusting for
covariates adults with RA and depression were more than 2
times as likely to report any functional limitations (AOR =
2.24; 95% CI = 1.62, 3.10) (Table 3).
3.3. Humanistic Outcomes. Adults with RA and depression
reported significantly lower HRQoL scores in both Physical
Component Summary score (35.1 versus 40.2, 𝑝 < .001)
and Mental Component Summary score (37.2 versus 48.7,
𝑝 < .001) compared to adults with RA without depression
(Table 4). In adjusted analyses, a significant difference was
observed only in the mental domain of the HRQoL; the
presence of depression was associated with a decrement of
8.72 in MCS scores (Table 4). The counterfactual predictions
yielded similar differences in MCS (37.19 in adults with
depression versus 45.91 in adults without depression, 𝑝 <
.001). The relationship between depression and PCS scores
became insignificant after adjustment for the presence of
multiple chronic conditions.
3.4. Economic Outcomes
3.4.1. Direct Total Healthcare Expenditures. In unadjusted
analysis, adults with RA and depression had significantly
higher annual healthcare expenditures ($17,941 versus
$10,064 𝑝 < .001). In the adjusted GLM with gamma distri-
bution and log-link, we found that depression was associated
with greater total healthcare expenditures compared to those
without depression (Beta = 0.34, SE = 0.08). When converted
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Table 1: Description of study sample. Working-age (18 to 64 years)
adultswithRheumatoidArthritisMedical Expenditure Panel Survey
(2009, 2011, 2013, and 2015).
𝑁 Weighted𝑁 Weighted%
All 2,662 5,719,998 100.0
Gender
Female 1,826 3,661,958 64.0
Male 836 2,058,040 36.0
Race/ethnicity
White 1,061 3,596,249 62.9
African American 778 989,822 17.3
Latino 639 780,416 13.6
Others 184 353,511 6.2
Age in years
18–39 years 444 956,652 16.7
40–49 years 609 1,271,670 22.2
50–59 years 1,080 2,326,292 40.7
60–64 years 529 1,165,384 20.4
Marital status
Married 1,287 3,098,420 54.2
Widow/separated/divorced 845 1,630,180 28.5
Never married 530 991,398 17.3
Education
Less than high school 665 1,007,827 17.6
High school 939 2,043,963 35.7
More than high school 1,036 2,623,400 45.9
Poverty status
Poor 740 1,216,767 21.3
Not poor 675 1,204,168 21.1
Middle income 708 1,670,010 29.2
High income 539 1,629,054 28.5
Insurance status
Private 1,302 3,411,533 59.6
Public 932 1,580,322 27.6
Uninsured 428 728,144 12.7
Employment
Employed 1,309 3,071,100 53.7
Not employed 1,352 2,647,283 46.3
Region
Northeast 383 984,779 17.2
Midwest 523 1,264,228 22.1
South 1,190 2,454,395 42.9
West 566 1,016,597 17.8
Perceived physical health
Excellent/very good 607 1,488,614 26.0
Good 871 2,001,187 35.0
Fair/poor 1,184 2,230,197 39.0
Perceived mental health
Excellent/very good 607 1,488,614 26.0
Good 871 2,001,187 35.0




RA only 716 1,605,886 28.1
Multimorbidity 1,946 4,114,112 71.9
Anxiety
Yes 494 1,134,341 19.8
No 2,168 4,585,657 80.2
Obesity
Obese 1,218 2,521,340 44.1
Not obese 1,392 3,084,702 53.9
Smoking status
Current smoker 698 1,567,457 27.4
Others 1,755 3,729,925 65.2
Missing 209 422,616 7.4
Exercise
Yes 1,077 2,364,802 41.3
No 1,568 3,321,567 58.1
Note. Based on 2,662 adults with Rheumatoid Arthritis, aged between 18
and 64 years, who were alive during the calendar year. Missing data for
the variables, education, obesity, smoking, and exercise, are not presented.
Weighted𝑁 and percentages were derived by dividing the person weights by
the number of years pooled.
to original dollars this represented $14,752 for those with
depression and $10,541 for those without depression
(Table 5). Estimates from counter-factual recycled prediction
revealed that depression was associated with an excess of
$4,212 total healthcare expenditures with 95% CI = $4,114,
$4,318.
In unadjusted analysis, patients/families in the RA +
depression group spent significantly higher amounts out-of-
pocket on health care compared to the RA + no depression
group ($1,443 versus $1,052, 𝑝 < .001). In the adjusted
GLM with gamma distribution and log-link, we found that
depression was associated with greater total out-of-pocket
healthcare spending compared to those without depression
(Beta = 0.23, SE = 0.06). When converted to original dollars
this represented $1,232 for those with depression and $979 for
those without depression (Table 5). Estimates from counter-
factual recycled prediction revealed that depression was
associated with an excess of $253 with 95% CI = $247, 260.
When high out-of-pocket spending burden was mea-
sured as spending greater than 10% of income on healthcare,
we found that 30.7% of adults with depression and 21.3% of
adults without depression had high out-of-pocket spending
burden. After adjusting for other factors, adults with depres-
sion were significantly more likely to have high out-of-pocket
spending burden (AOR = 1.34; 95% CI = 1.01, 1.79).
3.4.2. Indirect Economic Burden
Labor Market Outcome (Unemployment), Missed Work Days,
and Lost Wages. Presence of depression was significantly
associated with unemployment among adults with RA; 64.1%
of adults with depression were unemployed compared to
6 Arthritis
Table 2: Description of study sample by depression amongworking-age (18–64 years) adults with Rheumatoid ArthritisMedical Expenditure
Panel Survey (2009, 2011, 2013, and 2015).
RA with depression RA without depression Sig
𝑁 Wt.𝑁 Wt. Row% 𝑁 Wt.𝑁 Wt. Row%
All 647 369,136 2,015 1,060,864
Gender ∗∗∗
Female 502 270,895 29.6 1,324 644,595 70.4
Male 145 98,241 19.1 691 416,269 80.9
Race/ethnicity ∗∗∗
White 328 264,578 29.4 733 634,485 70.6
African American 157 45,643 18.4 621 201,813 81.6
Latino 127 40,938 21 512 154,166 79
Others 35 17,977 20.3 149 70,400 79.7
Age in years
18–39 years 98 58,925 24.6 346 180,238 75.4
40–49 years 149 82,063 25.8 460 235,855 74.2
50–59 years 281 156,442 26.9 799 425,131 73.1
60–64 years 119 71,706 24.6 410 219,640 75.4
Marital status ∗∗∗
Married 248 160,488 20.7 1,039 614,118 79.3
Widow/separated/divorced 259 139,902 34.3 586 267,643 65.7
Never married 140 68,746 27.7 390 179,104 72.3
Education
Less than high school 170 65,953 26.2 495 186,004 73.8
High school 232 138,615 27.1 707 372,376 72.9
Missing 4 2,236 20 18 8,966 80
Poverty status ∗∗∗
Poor 236 103,612 34.1 504 200,580 65.9
Not poor 185 88,172 29.3 490 212,870 70.7
Middle income 141 101,112 24.2 567 316,391 75.8
High income 85 76,241 18.7 454 331,023 81.3
Insurance status ∗∗∗
Private 235 183,245 21.5 1,067 669,638 78.5
Public 345 153,607 38.9 587 241,474 61.1
Uninsured 67 32,284 17.7 361 149,752 82.3
Employment ∗∗∗
Employed 195 132,391 17.2 1,114 635,384 82.8
Not employed 452 236,745 35.8 900 425,076 64.2
Region
Northeast 89 50,671 20.6 294 195,524 79.4
Midwest 157 93,289 29.5 366 222,768 70.5
South 271 161,001 26.2 919 452,598 73.8
West 130 64,175 25.3 436 189,975 74.7
Perceived physical health status ∗∗∗
Excellent/very good 72 46,019 12.4 535 326,135 87.6
Good 165 110,972 22.2 706 389,325 77.8
Fair/poor 410 212,145 38 774 345,405 62
Perceived mental health status ∗∗∗
Excellent/very good 113 74,855 11.7 995 565,345 88.3
Good 207 122,356 25.1 730 365,098 74.9
Fair/poor 327 171,925 56.9 290 130,422 43.1
Multimorbidity ∗∗∗
RA only 110 69,703 17.4 606 331,768 82.6
Multimorbidity 537 299,433 29.1 1,409 729,096 70.9
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Table 2: Continued.
RA with depression RA without depression Sig
𝑁 Wt.𝑁 Wt. Row% 𝑁 Wt.𝑁 Wt. Row%
Anxiety ∗∗∗
Yes 259 150,809 53.2 235 132,776 46.8
No 388 218,327 19 1,780 928,088 81
Obesity ∗∗
Obese 353 190,757 30.3 865 439,579 69.7
Not obese 287 172,382 22.4 1,105 598,794 77.6
Smoking status ∗∗∗
Current smoker 250 142,876 36.5 448 248,988 63.5
Others 355 204,588 21.9 1,400 727,893 78.1
Exercise ∗∗∗
Yes 190 106,306 18 887 484,895 82
No exercise 454 259,932 31.3 1,114 570,460 68.7
Note. Based on 2,662 adults with Rheumatoid Arthritis aged between 18 to 64 years, who were alive during the calendar year. Missing data for the variables,
education, obesity, smoking, and exercise, are not presented. Asterisks represent significant group differences by the presence of depression based on chi-square
tests. Weighted𝑁 and percentages were derived by dividing the person weights by the number of years pooled; Wt.: weighted; ∗∗∗𝑝 < .001; .001 ≤ ∗∗𝑝 < .01.
Table 3: Clinical outcome associated with depression among working-age adults with Rheumatoid Arthritis Medical Expenditure Panel
Survey (2009, 2011, 2013, and 2015).








Pain interference with daily activity ∗∗∗
Mild/none 155 29.8 918 51.9
Moderate 92 15.4 317 17.3
Severe (extreme/quite a lot) 358 54.8 640 30.8
Limitations
Any functional limitations 528 79.0 1,026 51.1 ∗∗∗
Adjusted odds ratio and 95% CI for depression from multinomial logistic regression on pain interference with normal activity
AOR 95% CI Sig
Pain interference with daily activity
Mild/none (reference group)
Moderate 1.37 [0.91, 2.06]
Severe 2.22 [1.55, 3.18] ∗∗∗
Adjusted odds ratio and 95% CI for depression from logistic regression on limitations
AOR 95% CI Sig
Limitations
Any functional limitations 2.24 [1.62, 3.10] ∗∗∗
Note. Based on 2,662 adults with Rheumatoid Arthritis aged between 18 and 64 years, who were alive during the calendar year. Adjusted multinomial logistic
regression controlled sex, race/ethnicity, age, region, marital status, education, family poverty status, health insurance, physical health status, mental health
status, anxiety, multimorbidity, obesity, physical activity, and smoking. Asterisks represent significant group differences by the presence of depression; ∗∗∗𝑝 <
.001; ADL: activities of daily living; Col: column; IADL: instrumental activities of daily living; Wt.: weighted.
40.1% adults without depression. Even after controlling for
other factors mentioned in the methods section, adults with
RA and depression were 1.55 times as likely as those without
depression to be unemployed (AOR = 1.55; 95% CI = 1.14,
2.10). Among employed adults, those with depression had
significantly higher number of missed work days annually (9
versus 6, 𝑝 < .05) and higher lost wages ($813 versus $571,
𝑝 < .05) due to missed work (Table 5). We obtained similar
results with counterfactual recycled predictions.
4. Discussion
In this study using a nationally representative sample of
community-dwelling US adults, one in four working-age
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Table 4: Humanistic outcomes (health-related quality of measures) by presence of depression among working-age adults with Rheumatoid
Arthritis Medical Expenditure Panel Survey (2009, 2011, 2013, and 2015).
RA + depression RA and no depression Sig
Wt. mean SE Wt. mean SE
All 𝑁 = 647 𝑁 = 2,015
Physical component summary score 35.07 0.89 40.18 0.47 ∗∗∗
Mental component summary
score 37.20 0.77 48.74 0.37 ∗∗∗
Fully adjusted model: parameter estimates and standard errors for depression ordinary least squares regression mental component
summary score
Beta Standard error Sig
Depression −8.72 0.81 ∗∗∗
No depression (reference group)
Fully adjusted model: parameter estimates and standard errors for depression ordinary least squares regression physical
component summary score
Beta Standard error Sig
Depression −1.29 0.81
No depression (reference group)
Note. Based on 2,662 adults with Rheumatoid Arthritis aged between 18 and 64 years, who were alive during the calendar year. Asterisks represent significant
group differences by the presence of depression. The ordinary least squares regressions controlled for the following variables: sex, race/ethnicity, age, region,
marital status, education, family poverty status, health insurance, anxiety, multimorbidity, obesity, physical activity, and smoking; SE: standard error; Wt.:
weighted; ∗∗∗𝑝 < .001.
adults with RA reported depression.This rate is considerably
higher compared to the 6.8% rate of depression in the
general population in the US [27] and higher than the
pooled depression rate of 16.8% reported by Matcham and
colleagues in ameta-analysis of 72 studies that included 13,189
RA patients [5]. The same meta-analysis also reported the
presence of depressive symptoms in 38.8% of RA patients
measured using Patient Health Questionnaire (PHQ-9) and
34.2% of RA patients measured using Hospital Anxiety and
Depression Scale (HADS) [5]. Therefore, the differences in
the rate of depression in RA patients can be explained by the
differences in the instruments used to identify depression.
Our study findings indicated the substantial additional
clinical burden imposed by depression in working-age adults
with RA.These findings have implications for comanagement
of depression and RA. Although not specific to RA, a
randomized clinical trial of 1,001 patients with concurrent
depression and arthritis and seeking care from 18 primary
care clinics [28] suggested that collaborative depression care
not only reduced depressive symptoms but also improved
arthritis related outcomes, such as decreasing pain and
functional limitations. There is some evidence that disease-
modifying drugs used to treat RA can have spill-over effects
in reducing depressive symptoms. For example, depression
levels decreased significantly following commencement and
continuity of rituximab, a B cell-directed therapy, among
individuals with RA [29]. Therefore, future studies need
to systematically evaluate whether antirheumatic treatment
among individuals with RA can help alleviate depressive
symptoms.
We also observed significant decrements in HRQoL
measures, specifically the MCS scores. This is not surprising;
however, it is important given the strong association between
patient-reported outcomes and disease activity [30]. It has
also been suggested that patient-reported outcomes such as
the HRQoL and other measures in clinical trials and routine
clinical practice may shed light on variations in treatment
response as well as the burden of disease among RA adults
[30, 31]. Our findings suggest that collecting patient-reported
HRQoL can be critical in assessing disease burden that may
not be captured by clinical assessment alone [30].
Depression in working-age adults with RAwas associated
with substantial direct and indirect economic burden. For
example, the presence of depression more than doubled the
annual per person total healthcare costs, a number of missed
work days, and lost wages due tomissed work days, even after
controlling for predisposing factors, enabling characteristics,
need factors, and personal health care practices. Although
published evidence on the incremental economic impact
of depression in RA is limited [9], our findings which are
consistent with studies assessing the burden of depression
on other chronic illnesses such as diabetes, cardiovascular
disease, and asthma have also reported the synergistic effect
of depression in increasing the economic burden among
individuals with chronic conditions [12, 32].
Our findings on the economic burden of depression in
RA patients have important implications for the payers as it
highlights an opportunity for reducing expenditures in RA
patients by increasing efforts towards screening and effec-
tively treating depression in RA patients. Potential strategies
could be improving the integration of mental health services
with rheumatology practice and facilitating mental health
training for rheumatologists. Future studies need to explore
whether treatment for depression provides an opportunity
to reduce direct healthcare expenditures associated with
depression in RA patients.
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Table 5: Economic outcomes by presence of depression among working-age adults with Rheumatoid Arthritis Medical Expenditure Panel
Survey (2009, 2011, 2013, and 2015).
RA + depression RA and no depression Sig
Wt. mean SE Wt. mean SE
All 𝑁 = 647 𝑁 = 2,015
Total healthcare expenditures (2015 $) 17,941 1489 10,064 574 ∗∗∗
Total out-of-pocket spending by
patients/families (2015 $) $1,443 135 $1,052 73 ∗∗∗
Adjusted total direct healthcare expenditures of depression from generalized linear models with gamma distribution and log link
Wt. mean 95% CI Wt. mean 95% CI Sig
∗∗∗
Total healthcare expenditures (2015 $) 14,752 (14,411–15,125) 10,541 (10,206–10,806)
Total out-of-pocket spending by
patients/families (2015 $) 1,232 (1,202–1265) 979 (955–1,005) ∗∗∗
Incremental total direct healthcare expenditures of depression from counterfactual recycled prediction
Wt. mean 95% CI
Total healthcare expenditures (2015 $) 4,212 (4,114, 4318) ∗∗∗
Total out-of-pocket spending by
patients/their families (2015 $) 253 (247–260) ∗∗∗
High out-of-pocket spending burden (>10% income spent on healthcare)
RA + depression RA and no depression
𝑁 Wt. col% 𝑁 Wt. col%
High out-of-pocket spending burden 192 30.7 424 21.3 ∗∗∗
Fully adjusted model: adjusted odds ratio (AOR) and 95% confidence intervals (CI) of Depression from logistic regression on high
out-of-pocket burden
AOR 95% CI Sig
Depression 1.34 [1.01, 1.79] ∗∗
No depression (reference)
Unemployment among working-age adults
RA + depression RA and no depression
𝑁 Wt. col% 𝑁 Wt. col%
Unemployed 452 64.1 900 40.1 ∗∗∗
Fully adjusted model: adjusted odds ratio (AOR) and 95% confidence intervals (CI) of depression from logistic regression on
unemployment
AOR 95% CI Sig
Depression 1.55 [1.14, 2.10] ∗∗∗
No depression (reference)
Fully adjusted models: total productivity losses by depression from negative binomial regression on missed work Days
Wt. mean 95% CI Wt. mean 95% CI Sig
∗∗∗
Number of missed work days 9.0 (8.7–9.4) 6.0 (5.7–6.2)
Lost wages 853 (833–873) 571 (558–584) ∗∗∗
Incremental total productivity losses associated with depression from counterfactual recycled prediction
Wt. mean 95% CI
Number of missed work days 3.1 (2.9–3.2) ∗
Lost wages 282 (276–289) ∗
Note. Based on 2,662 adults with Rheumatoid Arthritis aged between 18 and 64 years, who were alive during the calendar year. Asterisks represent significant
group differences by the presence of depression.The adjusted models squares regressions controlled for the following variables: sex, race/ethnicity, age, region,
marital status, education, family poverty status, health insurance, physical health, mental health status, anxiety, multimorbidity, obesity, physical activity, and
smoking. Missed work days and lost wages were estimated only for those who were employed; ∗∗∗𝑝 < .001; .001 ≤ ∗∗𝑝 < .01; .01 ≤ ∗𝑝 < .05.
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The study findings have important implications for the
employers because depression costs US employers more than
$31 billion annually due to missed work and decreased
work performance [33]. One study done in the US reported
that depression leads to the highest reduction in work
performance and the highest employer burden relative to
any other chronic conditions [34]. Strategies that employers
may adopt to improve mental health in employees include
organizing workplace health promotion programs and stress
management projects, which have shown the benefits of
prevention and management of depression in workplace [35,
36].
To the best of our knowledge, this is the first population-
based study that comprehensively examined the excess
clinical, humanistic, and economic burden of depression
in working-age adults with RA. Other strengths of this
study include the use of nationally representative survey,
adjustment of a comprehensive list of confounders such
as predisposing factors, enabling factors, need factors, and
personal health care practices and the use of robust statistical
techniques such as GLM, and recycled prediction in estimat-
ing the incremental costs and missed workdays.
However, the findings of this study should be interpreted
considering its potential limitations. First, we did not control
for the severity and duration of RA and depression as MEPS
does not contain this information. These factors can be
important confounders of both healthcare costs and work
absence. Second, we have measured productivity loss as
missed work days and did not consider other kinds of
productivity loss such as reduced productivity while at work
(presenteeism) and loss of employment.
Our findings would provide valuable insights to pay-
ers and other decision-makers to better understand the
economic impact of comorbid depression on working RA
patients from US societal perspective. It is well-documented
that depression in RA patients is often underrecognized and
undertreated in routine clinical practice [37, 38]. Therefore,
our study underscores the need for incorporating depression
screening and management in the routine clinical manage-
ment of RA in order to offset the substantial incremental
costs associated with depression. Published evidence has
well documented that depression is a treatable condition.
However, it is still not clear whether depression treatment is
equally effective in RA patients as compared to those with
depression without RA [39]. Future studies need to assess the
potential cost reductions that can be achieved through early
detection and more aggressive treatment of depression in RA
patients.
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